Markets Digest Expected Fed Rate Cut With Modest Moves; Tech Slips on China Tensions

Markets mostly treaded water following the Federal Reserve’s well-telegraphed decision to cut interest rates by 25bps and signal two more cuts this year. The move marked the beginning of a long-anticipated easing cycle, but investor reaction was muted as most of the dovishness was already priced in. The S&P 500 ended marginally lower while the Dow gained, and Treasury yields rose modestly. Tech stocks underperformed amid renewed U.S.-China chip tensions, dragging the Nasdaq lower.

Key Headlines & Market Movers

• Fed Cuts 25bps Unsurprisingly, Signals Two More: The Fed delivered what markets expected: a 25bps rate cut and a dot plot that implies two more cuts before year-end. Chair Powell struck a cautious tone, citing rising risks to employment while reaffirming the Fed's commitment to the 2% inflation target. While the rate cut was unanimous save for one member seeking a deeper cut, Powell emphasized a “balanced” outlook rather than a full pivot. Market participants largely saw this as a defensive move to support labor markets, not an aggressive bid to reaccelerate growth.
• Market Reaction Muted as Easing Was Priced In: With easing well telegraphed since the soft July jobs report, the Fed’s decision landed without much fanfare. Stocks seesawed but closed mostly flat, with the S&P 500 off just 0.1%. Bond yields rose slightly, suggesting that the market had largely anticipated the move. Analysts noted a “buy the rumor, sell the news” feel to the day’s action, especially in a typically weak seasonal window like September.
• Tech Stocks Hit by China’s Nvidia Ban: Nvidia slid over 3.5% after reports surfaced that Chinese regulators ordered major domestic firms to halt purchases of its high-end AI chips. Broadcom and Palantir also fell sharply, dragging the Nasdaq 100 into negative territory. The development reignites concerns over tech decoupling and adds fresh geopolitical risk to the sector’s outlook.
• Corporate Highlights - StubHub, Workday, Eli Lilly: Workday surged 6% after Elliott Management disclosed a $2B stake, signaling activist involvement. StubHub's IPO stumbled post-debut, closing 5% lower despite an early pop. Meanwhile, Eli Lilly’s experimental diabetes drug outperformed an existing Novo Nordisk treatment in early trials, potentially expanding its lead in the fast-growing weight loss category.

S&P 500 Sector Performance

Looking Ahead

While the Fed’s dovish lean offers some reassurance, the path forward remains data-dependent. Investors will closely watch upcoming labor and inflation prints to gauge the timing and scope of further cuts. For now, equity markets appear to be consolidating recent gains while bonds may find support amid lingering economic uncertainty. Positioning for potential curve flattening and favoring intermediate bond maturities may offer the best balance in the current environment.

Disclaimer

Duncan Williams Asset Management is an SEC registered investment adviser. SEC registration does not constitute an endorsement of Duncan Williams Asset Management by the SEC nor does it indicate that Duncan Williams Asset Management has attained a particular level of skill or ability.

This material prepared by Duncan Williams Asset Management is for informational purposes only and is accurate as of the date it was prepared.  It is not intended to serve as a substitute for personalized investment advice or as a recommendation or solicitation of any particular security, strategy or investment product. Past performance is not indicative of future results. Investing involves risks, including the risk of loss of principal. Before making any investment decision, investors should consult with their financial advisor, consider their individual financial circumstances, and carefully review all relevant information and risk factors. Duncan Williams Asset Management assumes no responsibility for errors or omissions, nor does it accept liability for any loss arising from reliance on this information.

Advisory services are only offered to clients or prospective clients where Duncan Williams Asset Management and its representatives are properly licensed or exempt from licensure. No advice may be rendered by Duncan Williams Asset Management unless a client service agreement is in place.

This material is not intended to serve as personalized tax, legal and/or investment advice since the availability and effectiveness of any strategy is dependent upon your individual facts and circumstances. Duncan Williams Asset Management is not a legal or accounting firm. Please consult with your legal or tax professional regarding your specific tax situation when determining if any of the mentioned strategies are right for you.

‍